Responses
Cardiovascular medicine
Protocol
The effect of luseogliflozin and alpha-glucosidase inhibitor on heart failure with preserved ejection fraction in diabetic patients: rationale and design of the MUSCAT-HF randomised controlled trial
Compose a Response to This Article
Other responses
No responses have been published for this article.